The present invention relates to novel compounds that are novel adenosine receptor analogues. Specifically, the compounds of the present invention preferably function as both adenosine receptor agonists and ganglionic blocking agents. To achieve this functionality, the compounds of the present invention,...http://www.google.de/patents/US6995148?utm_source=gb-gplus-sharePatent US6995148 - Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
